|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.009 AUD | 0.00% |
|
0.00% | +12.50% |
| Apr. 10 | Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment | MT |
| Feb. 23 | Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Patrys Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was AUD 3.33 million compared to AUD 1.34 million a year ago. Net loss was AUD 6.78 million compared to AUD 4.06 million a year ago.
Basic loss per share from continuing operations was AUD 0.003458 compared to AUD 0.002524 a year ago. Diluted loss per share from continuing operations was AUD 0.003458 compared to AUD 0.002524 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.50% | 11.91M | |
| -1.82% | 41.35B | |
| +44.25% | 40.38B | |
| +2.56% | 39.05B | |
| -12.11% | 26.67B | |
| +3.09% | 24.07B | |
| -24.16% | 18.36B | |
| +22.12% | 11.6B | |
| -3.74% | 11.68B | |
| +7.75% | 11.15B |
PATRYS LIMITED 
